Antibiotic prophylaxis in total hip arthroplasty

Journal of Bone and Joint Surgery - Series B

Volumn 79, Issue 4, 1997, Pages 590-595

  Espehaug, B ^a   Engesaeter, L B ^a,b   Vollset, S E ^a   Havelin, L I ^a,b   Langeland, N ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Buskerud Central Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; CEFALOTIN; CEFUROXIME; CLOXACILLIN; COLISTIN; DICLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; PALACOS;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; CONFERENCE PAPER; CONTROLLED STUDY; COXITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OPERATING ROOM; OPERATION DURATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS FIXATION; PROSTHESIS LOOSENING; REOPERATION; TOTAL HIP PROSTHESIS;

ANTIBIOTIC PROPHYLAXIS; BONE CEMENTS; HIP PROSTHESIS; HUMANS; NORWAY; OSTEOARTHRITIS, HIP; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSTHESIS FAILURE; REGISTRIES; REGRESSION ANALYSIS; REOPERATION;

EID: 0030738582     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.79B4.7420     Document Type: Conference Paper

References (37)

1. Murray DW, Carr AJ, Bulstrode CJ. Which primary total hip replacement? J Bone Joint Surg [Br] 1995;77-B:520-7.
2. Ahnfelt L, Herberts P, Malchau H, Andersson GBJ. Prognosis of total hip replacement: a Swedish multicenter study of 4,664 revisions. Acta Orthop Scand 1990;61 Suppl 238:1-26.
3. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden: follow-up of 92 675 operations performed 1978-1990. Acta Orthop Scand 1993;64:497-506.
4. Havelin LI, Espehaug B, Vollset SE, Engesaeter LB. Early failures among 14,009 cemented and 1,326 uncemented prostheses for primary coxarthrosis: The Norwegian Arthroplasty Register, 1987-1992. Acta Orthop Scand 1994;65:1-6.
5. Havelin LI, Espehaug B, Vollset SE, Engesaeter LB. Early aseptic loosening of uncemented femoral components in primary total hip replacement: a review based on the Norwegian arthroplasty register. J Bone Joint Surg [Br] 1995;77:11-7.
6. Havelin LI, Espehaug B, Vollset SE, Engesaeter LB. The effect of the type of cement on early revision of Charnley total hip prostheses: a review of eight thousand five hundred and seventy-nine primary arthroplasties from the Norwegian arthroplasty register. J Bone Joint Surg [Am] 1995;77-A:1543-50.
7. Havelin LI, Vollset SE, Engesaeter LB. Revision for aseptic loosening of uncemented cups in 4352 primary total hip prostheses: a report from the Norwegian arthroplasty register. Acta Orthop Scand 1995;66:494-500.
8. Espehaug B, Havelin LI, Engesaeter LB, Vollset SE, Langeland N. Early revision among 12 179 hip prostheses: a comparison of 10 different brands reported to the Norwegian Arthroplasty Register, 1987-1993. Acta Orthop Scand 1995;66:487-93.
9. Norden CW. Prevention of bone and joint infections. Am J Med 1985;78(Suppl 6B):229-32.
10. Kaiser AB. Antimicrobial prophylaxis in surgery. New Eng J Med 1986;315:1129-38.
11. Doyon F, Evrard J, Mazas F. An evaluation of therapeutic trials published à propos of antibiotic prophylaxis in orthopaedic surgery. Rev Chir Orthop 1989;75:72-6. (Engl Abstr.)
12. Oishi CS, Carion WV, Hoaglund FT. Use of parenteral prophylactic antibiotics in clean orthopaedic surgery: a review of the literature. Clin Orthop 1993;296:249-55.
13. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty: a ten-year survey of 1688 hips. Clin Orthop 1993;292:210-4.
14. Trippel SB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg [Am] 1986;68:1297-302.
15. Havelin LI, Espehaug B, Vollset SE, Engesaeter LB, Langeland N. The Norwegian arthroplasty register: a survey of 17 444 hip replacements 1987-1990. Acta Orthop Scand 1993;64:245-51.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34:187-220.
18. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
19. Statistical Sciences Inc. S-PLUS User's Manual. Seattle: Statistical Sciences, Inc, 1995.
20. SPSS Inc. SPSS Advanced Statistics. Chicago: SPSS Inc, 1993.
21. Dixon WJ. BMDP statistical software manual. Berkeley, etc: University of California Press, 1992.
22. Pavel A, Smith RL, Ballard A, Larson IJ. Prophylactic antibiotics in elective orthopaedic surgery: a prospective study of 1591 cases. South Med J 1977;70 Suppl 1:50-5.
23. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet 1981;i:795-7.
24. Doyon F, Evrard J, Mazas F, Hill C. Long-term results of prophylactic cefazolin versus placebo in total hip replacement. Lancet 1987;1:860.
25. Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970;40:511-5.
26. Buchholz HW, Engelbrecht E, Röttger J, Siegel A. Erkenntnisse nach eechsel von über 400 infizierten hüftendoprothesen. Orthop Praxis 1977;12:1117-20.
27. Thierse L. Erfahrungen mit Refobacin-Palacos im hinblick auf die tiefen spätinfektionen nach hüftendoprosthesenoperationen: eine 4-jahres studie. Z Orthop 1978;116:847-52. (Engl. Abstr.)
28. Josefsson G, Lindberg L, Wiklander B. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop 1981;159: 194-200.
29. Josefsson G, Gudmundsson G, Kolmert L, Wijkström S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty: a five-year survey of 1688 hips. Clin Orthop 1990; 253:173-8.
30. McQueen MM, Hughes SPF, May P, Verity L. Cefuroxime in total joint arthroplasty: intravenous or in bone cement. J Arthroplasty 1990; 5:169-72.
31. Carlsson ÅS, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 1977;48:405-10.
32. Santavirta S, Takagi M, Konttinen YJ, Sorsa T, Suda A. Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother 1996;40:244-6.
33. Garvin KL, Salvati EA, Brause BD. Role of gentamicin-impregnated cement in total joint arthroplasty. Orthop Clin North Am 1988;19: 605-10.
34. Marks KE, Nelson CL, Lautenschlager EP. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg [Am] 1976;58-A:358-64.
35. Lidwell OM, Lowbury EJL, Whyte W, et al. Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors. J Hyg (Lond) 1984;93:505-29.
36. Lidwell OM. Air, antibiotics and sepsis in replacement joints. J Hosp Infect 1988;11 (Suppl C):18-40.
37. Hanssen AD, Osmon DR. Prevention of deep wound infection after total hip arthroplasty: the role of prophylactic antibiotics and clean air technology. Sem Arthroplasty 1994;5:114-21.